Provided by Tiger Fintech (Singapore) Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS-WS

0.084
-0.007-7.69%
Volume:88.59K
Turnover:7.29K
Market Cap:- -
PE:- -
High:0.091
Open:0.091
Low:0.077
Close:0.091
Loading ...

Company Profile

Company Name:
PARADIGM BIOPHARMACEUTICALS-WS
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.